ImmuCell
ICCC
13 hedge funds and large institutions have $1.27M invested in ImmuCell in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and closing their positions.
25% more capital invested
Capital invested by funds: $1.01M → $1.27M (+$257K)
8% more funds holding
Funds holding: 12 → 13 (+1)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
+$126K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$49K |
| 3 |
Renaissance Technologies
New York
|
+$10.8K |
| 4 |
U
UBS
Zurich,
Switzerland
|
+$514 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$58K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$9.34K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$720 |
| 4 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$524 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$196 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HP
1
HealthInvest Partners
Stockholm,
Sweden
| $524K | +$126K | +26,873 | +34% |
|
|
SRC
2
Shufro Rose & Co
New York
| $263K | – | – | – |
|
|
SKK
3
Shepherd Kaplan Krochuk
Boston,
Massachusetts
| $171K | – | – | – |
|
|
EFS
4
Essex Financial Services
Essex,
Connecticut
| $118K | – | – | – |
|
|
5
Renaissance Technologies
New York
| $88K | +$10.8K | +2,300 | +15% |
|
|
6
Vanguard Group
Malvern,
Pennsylvania
| $52K | +$49K | +10,475 | New |
|
|
7
Morgan Stanley
New York
| $26K | -$58K | -12,400 | -70% |
|
|
8
Bank of America
Charlotte,
North Carolina
| $10K | -$196 | -42 | -2% |
|
|
U
9
UBS
Zurich,
Switzerland
| $10K | +$514 | +110 | +6% |
|
|
GSC
10
Ground Swell Capital
Folly Beach,
South Carolina
| $2K | -$524 | -112 | -22% |
|
11
Creative Planning
Overland Park,
Kansas
| $2K | – | – | – |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| $1K | -$720 | -154 | -60% |
|
|
13
Wells Fargo
San Francisco,
California
| – | -$9.34K | -1,998 | -100% |
|
ICCC Hedge Fund Activity: Q3 2014 in Review
13 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q3 2014, worth a combined $1.27M — up 25% from $1.01M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ICCC positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 5 trimmed.
The largest buyer was HealthInvest Partners, adding an estimated $126K. The largest seller was Morgan Stanley, cutting an estimated $58K.
- 13 institutional investors held ImmuCell (ICCC) as of Q3 2014, up from 12 in Q2 2014.
- Funds reported $1.27M of ImmuCell stock for Q3 2014, up 25% quarter-over-quarter.
- 1 fund opened new ImmuCell positions in Q3 2014 and 0 closed out, a net change of +1 holder.
- The largest ImmuCell buyer in Q3 2014 was HealthInvest Partners, an estimated $126K added.
- The largest ImmuCell seller in Q3 2014 was Morgan Stanley, an estimated $58K sold.
Based on aggregated 13F filings for Q3 2014.